Nomogram development for predicting ovarian tumor malignancy using inflammatory biomarker and CA-125

Gatot Nyarumenteng Adhipurnawan Winarno1, Ali Budi Harsono2, Dodi Suardi2

  • 1Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Prof Eykman Street No 38, Bandung, 40161, Indonesia. gatot.nyarumenteng@unpad.ac.id.

Scientific Reports
|July 9, 2024
PubMed
Summary

This study found that elevated Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and CA-125 levels, along with lower Lymphocyte-to-Monocyte-Ratio (LMR), can help distinguish malignant from benign ovarian tumors. A nomogram model using these biomarkers improves diagnostic accuracy.

Related Concept Videos